Investors Research Corp Purchases Shares of 9,783 Envision Healthcare Co. (EVHC)
Investors Research Corp purchased a new stake in shares of Envision Healthcare Co. (NYSE:EVHC) during the fourth quarter, Holdings Channel reports. The firm purchased 9,783 shares of the company’s stock, valued at approximately $338,000.
Other large investors have also made changes to their positions in the company. CIBC World Markets Inc. purchased a new position in Envision Healthcare during the 4th quarter valued at about $208,000. Palisade Capital Management LLC NJ purchased a new position in Envision Healthcare during the 3rd quarter valued at about $229,000. CENTRAL TRUST Co increased its holdings in Envision Healthcare by 79.7% during the 4th quarter. CENTRAL TRUST Co now owns 6,626 shares of the company’s stock valued at $229,000 after purchasing an additional 2,939 shares during the period. Alps Advisors Inc. purchased a new position in Envision Healthcare during the 4th quarter valued at about $235,000. Finally, M&T Bank Corp increased its holdings in Envision Healthcare by 33.6% during the 4th quarter. M&T Bank Corp now owns 6,818 shares of the company’s stock valued at $235,000 after purchasing an additional 1,716 shares during the period.
Shares of Envision Healthcare Co. (EVHC) opened at $40.05 on Monday. The company has a debt-to-equity ratio of 0.87, a current ratio of 3.40 and a quick ratio of 3.38. The firm has a market capitalization of $4,841.62, a P/E ratio of -19.35, a P/E/G ratio of 0.98 and a beta of 0.48. Envision Healthcare Co. has a 52 week low of $23.77 and a 52 week high of $69.21.
EVHC has been the topic of a number of research analyst reports. Jefferies Group set a $41.00 price target on Envision Healthcare and gave the company a “buy” rating in a report on Tuesday, December 19th. Robert W. Baird set a $45.00 price target on Envision Healthcare and gave the company a “buy” rating in a report on Monday, February 26th. Cantor Fitzgerald restated a “hold” rating and set a $37.00 price target on shares of Envision Healthcare in a report on Friday, January 5th. Stephens reiterated a “hold” rating and set a $34.00 target price on shares of Envision Healthcare in a report on Wednesday, January 10th. Finally, ValuEngine downgraded Envision Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have assigned a buy rating to the company. Envision Healthcare has an average rating of “Hold” and an average target price of $42.23.
ILLEGAL ACTIVITY NOTICE: This article was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of international copyright laws. The original version of this article can be accessed at https://www.dailypolitical.com/2018/03/05/investors-research-corp-purchases-shares-of-9783-envision-healthcare-co-evhc.html.
Envision Healthcare Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Co. (NYSE:EVHC).
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.